معرفی
Dr. Abdullah Karadag is an Assistant Professor in the Department of Basic Medical Sciences at Adiyaman University Faculty of Medicine, specializing in Physiology. He has served in this position since November 1, 2022, after completing his Doctorate in Physiology from Eskişehir Osmangazi University Institute of Health Sciences.
Dr. Karadag's educational background includes:
- Doctorate (2013-2019): Eskişehir Osmangazi University, Institute of Health Sciences, Physiology
- Medical Degree (2001-2006): Istanbul University Cerrahpaşa Faculty of Medicine, Department of Medical and Biological Sciences
His primary research focuses on molecular physiology, particularly investigating microRNAs in cancer biology (especially prostate cancer), TNF-alpha signaling pathways, erythropoietin regulation, and the effects of various compounds on physiological processes. Dr. Karadag employs animal models extensively in his research to study disease mechanisms and potential therapeutic interventions, with a particular emphasis on molecular mechanisms underlying pathological conditions.
Dr. Karadag has published numerous articles in reputable journals with his most recent work including research on adropin's protective effects against renal ischemia-reperfusion injury, evaluation of microRNAs in prostate cancer, and studies on ghrelin and kisspeptin levels in liver tissue. His publication record shows consistent output across multiple disciplines within physiology and molecular biology, with particular concentration on cancer mechanisms, inflammatory pathways, and hormonal regulation.
His scientific contributions include:
- 16 peer-reviewed journal articles
- 13 conference proceedings
- Multiple research projects on microRNAs, prostate cancer, and physiological regulation mechanisms
Dr. Karadag teaches Physiology courses across multiple health science programs at Adiyaman University, including courses for Pharmacy, Nursing, Midwifery, and Eye Physiology programs. He has been actively involved in academic instruction since joining the university in 2013, progressing from Research Assistant to his current position as Assistant Professor.
His research group focuses on molecular mechanisms of disease, particularly examining how microRNAs regulate various physiological processes and their potential as therapeutic targets in conditions like prostate cancer. The laboratory utilizes various molecular biology techniques, animal models, and physiological assessment methods in their investigations, with current work expanding into the protective effects of compounds like adropin, quercetin, and vitamin D against tissue damage.
